Alumis (ALMS) insider trading in the last 6 months

Form 4 filings, newest first

Quality Score today -6

One insider bought $8.3M, 7 sold $1.5M.

BuySrinivas Akkaraju$2.9MDirectorat $10.63 on Sep 8, filed Sep 9

BuySrinivas AkkarajuDirector$2.9Mat $10.63 on Sep 8, filed Sep 9

BuySrinivas Akkaraju$2.9MDirectorat $10.63 on Sep 8, filed Sep 9

BuySrinivas AkkarajuDirector$2.9Mat $10.63 on Sep 8, filed Sep 9

BuySrinivas Akkaraju$2.5MDirectorat $11.17 on Sep 4, filed Sep 9

BuySrinivas AkkarajuDirector$2.5Mat $11.17 on Sep 4, filed Sep 9

From SEC Form 4s, the newest filed Sep 9, 2026 · Insiders have 2 business days to file a trade

9 more filings on ALMS in the last 6 months, for Pro members. See them free →

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

See all 12 tradesSee it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

Pro members see every filing on ALMS with what each insider bought or sold and at what price, and can turn on an optional alert when an insider buys.

Who files at Alumis

Insider trades by person

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

Questions about ALMS's insider trades

As of Nov 2, 2026: Alumis (ALMS) has 12 insider filings on record in the last 6 months, the newest filed Sep 9, 2026. Its Quality Score is -6 (Poor). Scores as of 5:08 PM ET, 15 minutes behind.

Are ALMS insiders buying or selling?

One insider bought $8.3M across 3 filings, and 7 insiders sold $1.5M across 9 filings, in the last 6 months. The newest filing: Srinivas Akkaraju, Director, bought $2.9M on Sep 8, 2026.

Who are ALMS's biggest insider sellers?

By the dollars of their sales in the last 6 months: Srinivas Akkaraju (Director), 2 sales; Sanam Pangali (Chief Legal Officer), 2 sales; John R. Schroer (Chief Financial Officer), 1 sale. 7 insiders sold in all.

When did an ALMS insider last buy?

Srinivas Akkaraju, Director, bought ALMS shares ($2.9M) on Sep 8, 2026, filed Sep 9, 2026, the newest insider buy on record.

Alumis's page has its Quality Score, its chart, and its earnings. More in Healthcare and Pharma. ALMS is on insider buys, Sep 7 to 13, 2026.